0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and Japan Meningococcal Disease Drugs Market Insights, Forecast to 2027
Published Date: September 2021
|
Report Code: QYRE-Auto-13H6796
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global and Japan Meningococcal Disease Drugs Market Insights Forecast to 2027

Global and Japan Meningococcal Disease Drugs Market Insights, Forecast to 2027

Code: QYRE-Auto-13H6796
Report
September 2021
147 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Meningococcal Disease Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Meningococcal Disease Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

Injectable
Oral

Segment by Application

Hospitals
Drugstores
Others

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

Pfizer
GlaxoSmithKline
Sanofi Pasteur
Novartis
Merck Sharp & Dohme
Hebei Hejia Pharmaceutical Technology Group Co., Ltd
Shandong Jincheng Pharmaceutical Group Co.,ltd.
Apeloa Pharmaceutical Co.,Ltd.
Yiling Pharmaceutical
Baiyunshan Pharmaceutical
SSY Group Limited
Lukang Pharmaceutical Co.,Ltd.
North China Pharmaceutical Company Ltd.
Harbin Pharmaceutical Group Co.,Ltd.
1 Study Coverage
1.1 Meningococcal Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Disease Drugs Market Size Growth Rate by Type
1.2.2 Injectable
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Meningococcal Disease Drugs Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meningococcal Disease Drugs Market Size, Estimates and Forecasts
2.1.1 Global Meningococcal Disease Drugs Revenue 2016-2027
2.1.2 Global Meningococcal Disease Drugs Sales 2016-2027
2.2 Global Meningococcal Disease Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Meningococcal Disease Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Meningococcal Disease Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Meningococcal Disease Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Meningococcal Disease Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Meningococcal Disease Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Meningococcal Disease Drugs Revenue Forecast by Region (2022-2027)
3 Global Meningococcal Disease Drugs Competitor Landscape by Players
3.1 Global Top Meningococcal Disease Drugs Manufacturers by Sales
3.1.1 Global Meningococcal Disease Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Meningococcal Disease Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Meningococcal Disease Drugs Manufacturers by Revenue
3.2.1 Key Meningococcal Disease Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Meningococcal Disease Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Meningococcal Disease Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Meningococcal Disease Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Meningococcal Disease Drugs Revenue in 2020
3.2.6 Global Meningococcal Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Meningococcal Disease Drugs Price by Manufacturers
3.4 Global Meningococcal Disease Drugs Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Disease Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Meningococcal Disease Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Meningococcal Disease Drugs Market Size by Type (2016-2021)
4.1.1 Global Meningococcal Disease Drugs Sales by Type (2016-2021)
4.1.2 Global Meningococcal Disease Drugs Revenue by Type (2016-2021)
4.1.3 Meningococcal Disease Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Meningococcal Disease Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Meningococcal Disease Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Meningococcal Disease Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Meningococcal Disease Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Meningococcal Disease Drugs Market Size by Application (2016-2021)
5.1.1 Global Meningococcal Disease Drugs Sales by Application (2016-2021)
5.1.2 Global Meningococcal Disease Drugs Revenue by Application (2016-2021)
5.1.3 Meningococcal Disease Drugs Price by Application (2016-2021)
5.2 Meningococcal Disease Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Meningococcal Disease Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Meningococcal Disease Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Meningococcal Disease Drugs Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Meningococcal Disease Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Meningococcal Disease Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Meningococcal Disease Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Meningococcal Disease Drugs Market Share in Global Market 2016-2027
6.2 Japan Meningococcal Disease Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Meningococcal Disease Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Meningococcal Disease Drugs Players by Revenue (2016-2021)
6.3 Japan Meningococcal Disease Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Meningococcal Disease Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Meningococcal Disease Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Meningococcal Disease Drugs Price by Type (2016-2021)
6.4 Japan Meningococcal Disease Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Meningococcal Disease Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Meningococcal Disease Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Meningococcal Disease Drugs Price Forecast by Type (2022-2027)
6.5 Japan Meningococcal Disease Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Meningococcal Disease Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Meningococcal Disease Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Meningococcal Disease Drugs Price by Application (2016-2021)
6.6 Japan Meningococcal Disease Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Meningococcal Disease Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Meningococcal Disease Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Meningococcal Disease Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Meningococcal Disease Drugs Market Size YoY Growth 2016-2027
7.2 North America Meningococcal Disease Drugs Market Facts & Figures by Country
7.2.1 North America Meningococcal Disease Drugs Sales by Country (2016-2021)
7.2.2 North America Meningococcal Disease Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Meningococcal Disease Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Meningococcal Disease Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Meningococcal Disease Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Meningococcal Disease Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Meningococcal Disease Drugs Market Size YoY Growth 2016-2027
9.2 Europe Meningococcal Disease Drugs Market Facts & Figures by Country
9.2.1 Europe Meningococcal Disease Drugs Sales by Country (2016-2021)
9.2.2 Europe Meningococcal Disease Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Meningococcal Disease Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Meningococcal Disease Drugs Market Facts & Figures by Country
10.2.1 Latin America Meningococcal Disease Drugs Sales by Country (2016-2021)
10.2.2 Latin America Meningococcal Disease Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Meningococcal Disease Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Meningococcal Disease Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Meningococcal Disease Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Meningococcal Disease Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Meningococcal Disease Drugs Products Offered
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Meningococcal Disease Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Corporation Information
12.3.2 Sanofi Pasteur Description and Business Overview
12.3.3 Sanofi Pasteur Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Pasteur Meningococcal Disease Drugs Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Meningococcal Disease Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Merck Sharp & Dohme
12.5.1 Merck Sharp & Dohme Corporation Information
12.5.2 Merck Sharp & Dohme Description and Business Overview
12.5.3 Merck Sharp & Dohme Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Merck Sharp & Dohme Meningococcal Disease Drugs Products Offered
12.5.5 Merck Sharp & Dohme Recent Development
12.6 Hebei Hejia Pharmaceutical Technology Group Co., Ltd
12.6.1 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Corporation Information
12.6.2 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Description and Business Overview
12.6.3 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Products Offered
12.6.5 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Recent Development
12.7 Shandong Jincheng Pharmaceutical Group Co.,ltd.
12.7.1 Shandong Jincheng Pharmaceutical Group Co.,ltd. Corporation Information
12.7.2 Shandong Jincheng Pharmaceutical Group Co.,ltd. Description and Business Overview
12.7.3 Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Products Offered
12.7.5 Shandong Jincheng Pharmaceutical Group Co.,ltd. Recent Development
12.8 Apeloa Pharmaceutical Co.,Ltd.
12.8.1 Apeloa Pharmaceutical Co.,Ltd. Corporation Information
12.8.2 Apeloa Pharmaceutical Co.,Ltd. Description and Business Overview
12.8.3 Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Products Offered
12.8.5 Apeloa Pharmaceutical Co.,Ltd. Recent Development
12.9 Yiling Pharmaceutical
12.9.1 Yiling Pharmaceutical Corporation Information
12.9.2 Yiling Pharmaceutical Description and Business Overview
12.9.3 Yiling Pharmaceutical Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Yiling Pharmaceutical Meningococcal Disease Drugs Products Offered
12.9.5 Yiling Pharmaceutical Recent Development
12.10 Baiyunshan Pharmaceutical
12.10.1 Baiyunshan Pharmaceutical Corporation Information
12.10.2 Baiyunshan Pharmaceutical Description and Business Overview
12.10.3 Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baiyunshan Pharmaceutical Meningococcal Disease Drugs Products Offered
12.10.5 Baiyunshan Pharmaceutical Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Meningococcal Disease Drugs Products Offered
12.11.5 Pfizer Recent Development
12.12 Lukang Pharmaceutical Co.,Ltd.
12.12.1 Lukang Pharmaceutical Co.,Ltd. Corporation Information
12.12.2 Lukang Pharmaceutical Co.,Ltd. Description and Business Overview
12.12.3 Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Lukang Pharmaceutical Co.,Ltd. Products Offered
12.12.5 Lukang Pharmaceutical Co.,Ltd. Recent Development
12.13 North China Pharmaceutical Company Ltd.
12.13.1 North China Pharmaceutical Company Ltd. Corporation Information
12.13.2 North China Pharmaceutical Company Ltd. Description and Business Overview
12.13.3 North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 North China Pharmaceutical Company Ltd. Products Offered
12.13.5 North China Pharmaceutical Company Ltd. Recent Development
12.14 Harbin Pharmaceutical Group Co.,Ltd.
12.14.1 Harbin Pharmaceutical Group Co.,Ltd. Corporation Information
12.14.2 Harbin Pharmaceutical Group Co.,Ltd. Description and Business Overview
12.14.3 Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Harbin Pharmaceutical Group Co.,Ltd. Products Offered
12.14.5 Harbin Pharmaceutical Group Co.,Ltd. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Meningococcal Disease Drugs Industry Trends
13.2 Meningococcal Disease Drugs Market Drivers
13.3 Meningococcal Disease Drugs Market Challenges
13.4 Meningococcal Disease Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningococcal Disease Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Meningococcal Disease Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Injectable
    Table 3. Major Manufacturers of Oral
    Table 4. Global Meningococcal Disease Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 5. Global Meningococcal Disease Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Meningococcal Disease Drugs Sales by Regions (2016-2021) & (K Units)
    Table 7. Global Meningococcal Disease Drugs Sales Market Share by Regions (2016-2021)
    Table 8. Global Meningococcal Disease Drugs Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Meningococcal Disease Drugs Sales Forecast by Region (2022-2027) & (K Units)
    Table 10. Global Meningococcal Disease Drugs Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Meningococcal Disease Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Meningococcal Disease Drugs Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Meningococcal Disease Drugs Sales by Manufacturers (2016-2021) (K Units)
    Table 14. Global Meningococcal Disease Drugs Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Meningococcal Disease Drugs Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Meningococcal Disease Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Meningococcal Disease Drugs Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Meningococcal Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Meningococcal Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Disease Drugs as of 2020)
    Table 20. Key Manufacturers Meningococcal Disease Drugs Price (2016-2021) (US$/Unit)
    Table 21. Meningococcal Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Meningococcal Disease Drugs Product Type
    Table 23. Date of International Manufacturers Enter into Meningococcal Disease Drugs Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Meningococcal Disease Drugs Sales by Type (2016-2021) (K Units)
    Table 26. Global Meningococcal Disease Drugs Sales Share by Type (2016-2021)
    Table 27. Global Meningococcal Disease Drugs Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Meningococcal Disease Drugs Revenue Share by Type (2016-2021)
    Table 29. Meningococcal Disease Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 30. Global Meningococcal Disease Drugs Sales Forecast by Type (2022-2027) & (K Units)
    Table 31. Global Meningococcal Disease Drugs Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Meningococcal Disease Drugs Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Meningococcal Disease Drugs Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Meningococcal Disease Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 35. Global Meningococcal Disease Drugs Sales by Application (2016-2021) (K Units)
    Table 36. Global Meningococcal Disease Drugs Sales Share by Application (2016-2021)
    Table 37. Global Meningococcal Disease Drugs Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Meningococcal Disease Drugs Revenue Share by Application (2016-2021)
    Table 39. Meningococcal Disease Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 40. Global Meningococcal Disease Drugs Sales Forecast by Application (2022-2027) & (K Units)
    Table 41. Global Meningococcal Disease Drugs Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Meningococcal Disease Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Meningococcal Disease Drugs Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Meningococcal Disease Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 45. Japan Meningococcal Disease Drugs Sales (K Units) of Key Companies (2016-2021)
    Table 46. Japan Meningococcal Disease Drugs Sales Share by Company (2016-2021)
    Table 47. Japan Meningococcal Disease Drugs Revenue (US$ Million) by Company (2016-2021)
    Table 48. Japan Meningococcal Disease Drugs Revenue Share by Company (2016-2021)
    Table 49. Japan Meningococcal Disease Drugs Sales (K Units) by Type (2016-2021)
    Table 50. Japan Meningococcal Disease Drugs Sales Share by Type (2016-2021)
    Table 51. Japan Meningococcal Disease Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. Japan Meningococcal Disease Drugs Price (US$/Unit) by Type (2016-2021)
    Table 53. Japan Meningococcal Disease Drugs Sales (K Units) by Type (2022-2027)
    Table 54. Japan Meningococcal Disease Drugs Sales Share by Type (2022-2027)
    Table 55. Japan Meningococcal Disease Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. Japan Meningococcal Disease Drugs Revenue Share by Type (2022-2027)
    Table 57. Japan Meningococcal Disease Drugs Price (US$/Unit) by Type (2022-2027)
    Table 58. Japan Meningococcal Disease Drugs Sales (K Units) by Application (2016-2021)
    Table 59. Japan Meningococcal Disease Drugs Sales Share by Application (2016-2021)
    Table 60. Japan Meningococcal Disease Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. Japan Meningococcal Disease Drugs Price (US$/Unit) by Application (2016-2021)
    Table 62. Japan Meningococcal Disease Drugs Sales (K Units) by Application (2022-2027)
    Table 63. Japan Meningococcal Disease Drugs Sales Share by Application (2022-2027)
    Table 64. Japan Meningococcal Disease Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. Japan Meningococcal Disease Drugs Revenue Share by Application (2022-2027)
    Table 66. Japan Meningococcal Disease Drugs Price (US$/Unit) by Application (2022-2027)
    Table 67. North America Meningococcal Disease Drugs Sales by Country (2016-2021) & (K Units)
    Table 68. North America Meningococcal Disease Drugs Sales Market Share by Country (2016-2021)
    Table 69. North America Meningococcal Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Meningococcal Disease Drugs Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Meningococcal Disease Drugs Sales by Region (2016-2021) & (K Units)
    Table 72. Asia Pacific Meningococcal Disease Drugs Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Meningococcal Disease Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Meningococcal Disease Drugs Revenue Market Share by Region (2016-2021)
    Table 75. Europe Meningococcal Disease Drugs Sales by Country (2016-2021) & (K Units)
    Table 76. Europe Meningococcal Disease Drugs Sales Market Share by Country (2016-2021)
    Table 77. Europe Meningococcal Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Meningococcal Disease Drugs Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Meningococcal Disease Drugs Sales by Country (2016-2021) & (K Units)
    Table 80. Latin America Meningococcal Disease Drugs Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Meningococcal Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Meningococcal Disease Drugs Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Meningococcal Disease Drugs Sales by Country (2016-2021) & (K Units)
    Table 84. Middle East and Africa Meningococcal Disease Drugs Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Meningococcal Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Meningococcal Disease Drugs Revenue Market Share by Country (2016-2021)
    Table 87. Pfizer Corporation Information
    Table 88. Pfizer Description and Business Overview
    Table 89. Pfizer Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 90. Pfizer Meningococcal Disease Drugs Product
    Table 91. Pfizer Recent Development
    Table 92. GlaxoSmithKline Corporation Information
    Table 93. GlaxoSmithKline Description and Business Overview
    Table 94. GlaxoSmithKline Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 95. GlaxoSmithKline Product
    Table 96. GlaxoSmithKline Recent Development
    Table 97. Sanofi Pasteur Corporation Information
    Table 98. Sanofi Pasteur Description and Business Overview
    Table 99. Sanofi Pasteur Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 100. Sanofi Pasteur Product
    Table 101. Sanofi Pasteur Recent Development
    Table 102. Novartis Corporation Information
    Table 103. Novartis Description and Business Overview
    Table 104. Novartis Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 105. Novartis Product
    Table 106. Novartis Recent Development
    Table 107. Merck Sharp & Dohme Corporation Information
    Table 108. Merck Sharp & Dohme Description and Business Overview
    Table 109. Merck Sharp & Dohme Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 110. Merck Sharp & Dohme Product
    Table 111. Merck Sharp & Dohme Recent Development
    Table 112. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Corporation Information
    Table 113. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Description and Business Overview
    Table 114. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 115. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Product
    Table 116. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Recent Development
    Table 117. Shandong Jincheng Pharmaceutical Group Co.,ltd. Corporation Information
    Table 118. Shandong Jincheng Pharmaceutical Group Co.,ltd. Description and Business Overview
    Table 119. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 120. Shandong Jincheng Pharmaceutical Group Co.,ltd. Product
    Table 121. Shandong Jincheng Pharmaceutical Group Co.,ltd. Recent Development
    Table 122. Apeloa Pharmaceutical Co.,Ltd. Corporation Information
    Table 123. Apeloa Pharmaceutical Co.,Ltd. Description and Business Overview
    Table 124. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 125. Apeloa Pharmaceutical Co.,Ltd. Product
    Table 126. Apeloa Pharmaceutical Co.,Ltd. Recent Development
    Table 127. Yiling Pharmaceutical Corporation Information
    Table 128. Yiling Pharmaceutical Description and Business Overview
    Table 129. Yiling Pharmaceutical Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 130. Yiling Pharmaceutical Product
    Table 131. Yiling Pharmaceutical Recent Development
    Table 132. Baiyunshan Pharmaceutical Corporation Information
    Table 133. Baiyunshan Pharmaceutical Description and Business Overview
    Table 134. Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 135. Baiyunshan Pharmaceutical Product
    Table 136. Baiyunshan Pharmaceutical Recent Development
    Table 137. SSY Group Limited Corporation Information
    Table 138. SSY Group Limited Description and Business Overview
    Table 139. SSY Group Limited Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 140. SSY Group Limited Product
    Table 141. SSY Group Limited Recent Development
    Table 142. Lukang Pharmaceutical Co.,Ltd. Corporation Information
    Table 143. Lukang Pharmaceutical Co.,Ltd. Description and Business Overview
    Table 144. Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 145. Lukang Pharmaceutical Co.,Ltd. Product
    Table 146. Lukang Pharmaceutical Co.,Ltd. Recent Development
    Table 147. North China Pharmaceutical Company Ltd. Corporation Information
    Table 148. North China Pharmaceutical Company Ltd. Description and Business Overview
    Table 149. North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 150. North China Pharmaceutical Company Ltd. Product
    Table 151. North China Pharmaceutical Company Ltd. Recent Development
    Table 152. Harbin Pharmaceutical Group Co.,Ltd. Corporation Information
    Table 153. Harbin Pharmaceutical Group Co.,Ltd. Description and Business Overview
    Table 154. Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 155. Harbin Pharmaceutical Group Co.,Ltd. Product
    Table 156. Harbin Pharmaceutical Group Co.,Ltd. Recent Development
    Table 157. Meningococcal Disease Drugs Market Trends
    Table 158. Meningococcal Disease Drugs Market Drivers
    Table 159. Meningococcal Disease Drugs Market Challenges
    Table 160. Meningococcal Disease Drugs Market Restraints
    Table 161. Meningococcal Disease Drugs Customers List
    Table 162. Meningococcal Disease Drugs Distributors List
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Meningococcal Disease Drugs Product Picture
    Figure 2. Global Meningococcal Disease Drugs Sales Market Share by Type in 2020 & 2027
    Figure 3. Injectable Product Picture
    Figure 4. Oral Product Picture
    Figure 5. Global Meningococcal Disease Drugs Sales Market Share by Application in 2020 & 2027
    Figure 6. Hospitals
    Figure 7. Drugstores
    Figure 8. Others
    Figure 9. Meningococcal Disease Drugs Report Years Considered
    Figure 10. Global Meningococcal Disease Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Meningococcal Disease Drugs Market Size 2016-2027 (US$ Million)
    Figure 12. Global Meningococcal Disease Drugs Sales 2016-2027 (K Units)
    Figure 13. Global Meningococcal Disease Drugs Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Meningococcal Disease Drugs Sales Market Share by Region (2016-2021)
    Figure 15. Global Meningococcal Disease Drugs Sales Market Share by Region in 2020
    Figure 16. Global Meningococcal Disease Drugs Revenue Market Share by Region (2016-2021)
    Figure 17. Global Meningococcal Disease Drugs Revenue Market Share by Region in 2020
    Figure 18. Global Meningococcal Disease Drugs Sales Share by Manufacturer in 2020
    Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Disease Drugs Revenue in 2020
    Figure 20. Meningococcal Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Meningococcal Disease Drugs Sales Market Share by Type (2016-2021)
    Figure 22. Global Meningococcal Disease Drugs Sales Market Share by Type in 2020
    Figure 23. Global Meningococcal Disease Drugs Revenue Market Share by Type (2016-2021)
    Figure 24. Global Meningococcal Disease Drugs Revenue Market Share by Type in 2020
    Figure 25. Global Meningococcal Disease Drugs Sales Market Share by Application (2016-2021)
    Figure 26. Global Meningococcal Disease Drugs Sales Market Share by Application in 2020
    Figure 27. Global Meningococcal Disease Drugs Revenue Market Share by Application (2016-2021)
    Figure 28. Global Meningococcal Disease Drugs Revenue Market Share by Application in 2020
    Figure 29. Japan Meningococcal Disease Drugs Sales Growth Rate 2016-2027 (K Units)
    Figure 30. Japan Meningococcal Disease Drugs Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 31. Japan Meningococcal Disease Drugs Market Share in Global Market 2016-2027
    Figure 32. Japan 5 and 10 Largest Meningococcal Disease Drugs Players Market Share by Revenue in Meningococcal Disease Drugs in 2020
    Figure 33. Japan Meningococcal Disease Drugs Revenue Share by Type (2016-2021)
    Figure 34. Japan Meningococcal Disease Drugs Revenue Growth Rate by Type in 2016 & 2020
    Figure 35. Japan Meningococcal Disease Drugs Revenue Share by Application (2016-2021)
    Figure 36. Japan Meningococcal Disease Drugs Revenue Growth Rate by Application in 2016 & 2020
    Figure 37. North America Meningococcal Disease Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 38. North America Meningococcal Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 39. North America Meningococcal Disease Drugs Sales Market Share by Country in 2020
    Figure 40. North America Meningococcal Disease Drugs Revenue Market Share by Country in 2020
    Figure 41. United States Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 42. United States Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Canada Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 44. Canada Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Europe Meningococcal Disease Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 46. Europe Meningococcal Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 47. Europe Meningococcal Disease Drugs Sales Market Share by Country in 2020
    Figure 48. Europe Meningococcal Disease Drugs Revenue Market Share by Country in 2020
    Figure 49. Germany Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 50. Germany Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 51. France Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 52. France Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. U.K. Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 54. U.K. Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. Italy Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 56. Italy Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Russia Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 58. Russia Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Asia Pacific Meningococcal Disease Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 60. Asia Pacific Meningococcal Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 61. Asia Pacific Meningococcal Disease Drugs Sales Market Share by Region in 2020
    Figure 62. Asia Pacific Meningococcal Disease Drugs Revenue Market Share by Region in 2020
    Figure 63. China Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 64. China Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 65. Japan Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 66. Japan Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. South Korea Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 68. South Korea Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. India Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 70. India Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. Australia Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 72. Australia Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. China Taiwan Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 74. China Taiwan Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Indonesia Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 76. Indonesia Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Thailand Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 78. Thailand Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Malaysia Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 80. Malaysia Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Latin America Meningococcal Disease Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 82. Latin America Meningococcal Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 83. Latin America Meningococcal Disease Drugs Sales Market Share by Country in 2020
    Figure 84. Latin America Meningococcal Disease Drugs Revenue Market Share by Country in 2020
    Figure 85. Mexico Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 86. Mexico Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 87. Brazil Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 88. Brazil Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 89. Argentina Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 90. Argentina Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Middle East and Africa Meningococcal Disease Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 92. Middle East and Africa Meningococcal Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 93. Middle East and Africa Meningococcal Disease Drugs Sales Market Share by Country in 2020
    Figure 94. Middle East and Africa Meningococcal Disease Drugs Revenue Market Share by Country in 2020
    Figure 95. Turkey Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 96. Turkey Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 97. Saudi Arabia Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 98. Saudi Arabia Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 99. UAE Meningococcal Disease Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 100. UAE Meningococcal Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. Meningococcal Disease Drugs Value Chain
    Figure 102. Channels of Distribution
    Figure 103. Distributors Profiles
    Figure 104. Bottom-up and Top-down Approaches for This Report
    Figure 105. Data Triangulation
    Figure 106. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart